MRI-guided laser ablation technology developer Monteris Medical has received U.S. Food and Drug Administration (FDA) clearance for its NeuroBlate Optic laser probe.
Designed for use with the NeuroBlate minimally invasive MRI-guided robotic laser thermotherapy system, the laser probe features fiber-optic controlled cooling and replaces a metal thermocouple on the NeuroBlate system with a nonmetallic, fiber-optic temperature sensor, according to the company. This sensor preserves controlled cooling and ablation capability while improving the probe's safety profile, Monteris said.
